Form D · Other Health Care

AION Biosystems, Inc.

Lowell, MA · CIK 0001972728

Offering snapshot reported Apr 11, 2024 · SEC filing

Reported sold
$2.5M
Offering amount: $5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 1, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 11, 2024Initial$2,499,899No comparison1SEC filing
Apr 11, 2024Initial$2,350,000No comparison11SEC filing
Apr 11, 2024Initial$4,325,000No comparison20SEC filing
Apr 27, 2023Initial$1,099,838No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-510366

Source: Form D, filed Apr 11, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Samara Barend Director, Executive
David Blechman Director
Peter Costantino Director
Ray Hood Director
Richard Miller Director
Todd O'connell Director
Alan Quasha Director
Tom Wilson Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
175 Cabot St.
Lowell, MA, 01854